EMA Press Briefing on COVID-19 related activities, 5 May 2022 twitter.com/i/broadcasts/1…
#COVID19 infections are still in the millions worldwide. This pandemic is far from over. COVID-19 will continue to impact our lives. #EMAPresser #pandemic
Vaccines are a central pillar of the response to the #pandemic. Nearly half a million lives among people 60 years of age and older have been saved in Europe thanks to #vaccination. #COVID19 #EMAPresser
Developers of #COVID19vaccines are investigating if bivalent vaccines offer advantages to monovalent vaccines. Results from ongoing #clinicaltrials are expected in the next couple of months. #EMAPresser
#ClinicalTrials for adapted vaccines should show they are superior to the current authorised #COVID19vaccines against #omicron and other variants. EMAPresser
Our priority is to ensure that adapted #COVIDvaccines are approved by September at the latest, to be ready for the rollout of new immunisation campaigns in the 🇪🇺 in autumn. This would allow manufacturers to adjust their production lines accordingly. #EMAPresser
It’s too early to consider using a 4th dose (2nd booster) of mRNA #COVID19vaccines in general population.
People over 80 years of age could benefit from a 2nd #booster, given the higher risk of severe #COVID19 for them. #EMAPresser
We have started evaluating an application for a #boosterdose in people over 18 years old for AstraZeneca’s #Vaxzevria. #COVID19 #EMAPresser
#Comirnaty can be used as a heterologous #booster in people who have received a different #COVID19vaccine during primary vaccination. #EMAPresser
We have started evaluating an application from Moderna to extend the use of #Spikevax to children from 6 months of age. This is the first application for this young age group. #EMAPresser #COVIDvaccines
For #Nuvaxovid, we are now assessing data to give a recommendation on its use in young people between 12 and 17 years old. #EMAPresser #Novavax #COVID19vaccines
Only 50% of Europeans are fully vaccinated & boosted. 15% of 🇪🇺citizens over 18 haven't received a single shot of the #COVID19vaccine.
‼️People who are not yet vaccinated or boosted should get their shot, especially if they are at a higher risk of severe disease. #EMAPresser

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with EU Medicines Agency

EU Medicines Agency Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @EMA_News

Jan 18
‼️ EMA’s regular press briefing on #COVID19 vaccines and treatments will be broadcast live 🔴 today, 18 January, from 16:00 to 16:30 CET. #EMAPresser
👉ema.europa.eu/en/events/ema-…
Watch live 🔴

We are now starting our regular press briefing on #COVID19 vaccines and treatments.

Don’t miss our tweets during the press briefing. Follow #EMAPresser.
👉 ema.europa.eu/en/events/ema-…
Omicron & other variants: Global regulators agreed that the administration of multiple booster doses at short intervals would not be sustainable in the long term. #COVID19 #EMAPresser #ICMRA
Read 10 tweets
Oct 5, 2021
‼️ EMA’s regular press briefing on #COVID19vaccines and treatments will be broadcast live 🔴 today, 5 October, from 14:00 to 14:30 CEST. #EMAPresser

👉ema.europa.eu/en/events/ema-…
Watch live 🔴

We are now starting our regular press briefing on #COVID19 vaccines and treatments. ema.europa.eu/en/events/ema-…

Don’t miss our tweets during the press briefing. Follow #EMAPresser.
EMA concluded that 3rd doses of #Comirnaty and #Spikevax may be given to people with severely weakened immune systems aged 12 or older, at least 28 days after their second dose. #EMAPresser
Read 16 tweets
Sep 9, 2021
Watch live 🔴

We are now starting our regular press briefing on #COVID19 vaccines and treatments.

Don’t miss our tweets during the press briefing. Follow #EMAPresser.
👉ema.europa.eu/en/events/ema-…
Currently approved #COVID19vaccines protect from the most acute consequence of this disease: hospitalisation and death. As many people as possible should be fully vaccinated. #EMAPresser
The evidence is becoming clearer on the need to consider additional vaccine doses for people who may poorly respond to #COVID19 vaccination, such as those with severely weakened immune systems or some elderly patients. #EMAPresser
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(